Log in

NYSE:NVONovo Nordisk A/S Earnings Date, Estimates & History

-0.61 (-0.96 %)
(As of 05/27/2020 04:00 PM ET)
Today's Range
Now: $62.79
50-Day Range
MA: $63.01
52-Week Range
Now: $62.79
Volume1.32 million shs
Average Volume1.96 million shs
Market Capitalization$147.86 billion
P/E Ratio24.62
Dividend Yield1.77%


Novo Nordisk A/S (NYSE:NVO) Earnings Information

Novo Nordisk A/S last announced its quarterly earnings data on May 6th, 2020. The reported $0.75 EPS for the quarter, beating the consensus estimate of $0.68 by $0.07. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.70 billion. Novo Nordisk A/S has generated $2.46 earnings per share over the last year and currently has a price-to-earnings ratio of 24.6. Novo Nordisk A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 14th, 2020 based off prior year's report dates.

Novo Nordisk A/S Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Novo Nordisk A/S (NYSE:NVO) Earnings Estimates

2020 EPS Consensus Estimate: $2.66
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201$0.73$0.73$0.73
Q2 20201$0.67$0.67$0.67
Q3 20201$0.66$0.66$0.66
Q4 20201$0.60$0.60$0.60

Novo Nordisk A/S (NYSE NVO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/6/20203/31/2020$0.68$0.75$0.75$4.70 billion$5.00 billionTranscript
2/5/2020Q4 2019$0.55$0.55$0.55$4.83 billion$4.80 billionN/A
11/1/20199/30/2019$0.62$0.64$0.64$4.55 billion$4.51 billionTranscript
8/9/2019Q2 2019$0.61$0.61$0.61$4.41 billion$4.52 billionN/A
5/3/2019Q1 2019$0.62$0.66$0.66$4.35 billion$4.46 billionN/A
2/1/201912/31/2018$0.57$0.54$0.54$4.36 billion$4.55 billionTranscript
11/1/2018Q3 2018$0.58$0.58$0.58$4.11 billion$4.31 billionN/A
8/8/2018Q2 2018$0.64$0.68$0.68$4.33 billion$4.39 billionN/A
5/2/2018Q1 2018$0.69$0.73$0.73$4.49 billion$4.44 billionN/A
2/1/2018Q4 2017$0.57$0.53$0.53$4.27 billion$4.43 billionN/A
11/1/2017Q3 2017$0.58$0.62$0.62$4.30 billion$4.20 billionN/A
8/10/2017Q2 2017$0.56$0.59$0.59$4.29 billion$4.23 billionN/A
5/3/2017Q1 2017$0.53$0.58$0.58$4.11 billion$4.08 billionN/A
2/2/2017Q4 2016$0.52$0.50$0.50$4.33 billion$4.29 billionN/A
10/28/2016Q3 2016$0.56$0.58$0.58$4.22 billion$4.13 billionN/A
8/5/2016Q2 2016$0.58$0.60$0.60$4.21 billion$4.17 billionN/A
4/29/2016Q1$0.53$0.55$0.55$4.07 billion$4.02 billionListen
2/3/2016Q4 2015$0.48$0.47$0.47$4.16 billion$4.24 billionN/A
10/29/2015Q3$0.47$0.49$0.49$4.03 billion$3.99 billionN/A
8/6/2015Q2 2015$0.48$0.48$3.97 billion$4.01 billionN/A
4/30/2015Q1$0.39$0.45$0.33$25.13 billion$25.20 billionN/A
1/30/2015Q4$2.48$0.38$0.38$24.67 billion$24.59 billionN/A
10/30/2014Q3 2014$0.42$0.42$3.80 billionN/A
8/7/2014Q2$2.60$0.48$0.48$21.86 billion$21.63 billionN/A
5/1/2014Q1$0.44$0.45$0.45$20.83 billion$20.30 billionN/A
1/30/2014Q4 2013$0.42$0.42$3.97 billionN/A
10/31/2013Q3 2013$0.44$0.44$21.04 billion$20.51 billionTranscript
8/8/2013Q2 2013$0.45$0.45$21.09 billion$21.38 billionN/A
5/1/2013Q1 2013$0.39$0.39$19.73 billion$19.98 billionN/A
1/31/2013$9.77$10.53$20.83 billion$20.96 billionTranscript
10/31/2012Q312$9.43$10.33$57.10 millionN/A
8/9/2012Q2 2012$0.32$0.32N/A
4/27/2012Q1 2012$0.30$0.30N/A
2/2/2012Q4 2011$0.26$0.30$0.30N/A
10/27/2011Q3 2011$0.27$0.28$0.28N/A
8/4/2011Q2 2011$0.29$0.28$0.28N/A
2/2/2011Q4 2010$0.27$0.25$0.25N/A
10/27/2010Q3 2010$0.23$0.23N/A
8/19/2010Q2 2010$0.19$0.21$0.21N/A
4/30/2010Q1 2009$0.16$0.16N/A
2/2/2010Q4 2009$0.16$0.16N/A
10/29/2009Q3 2009$0.18$0.18N/A
1/29/2009Q4 2008$0.13$0.13N/A
10/30/2008Q3 2008$0.17$0.17N/A
4/30/2008Q1 2008$0.14$0.14N/A
1/31/2008Q4 2007$0.06$0.06N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.